215 related articles for article (PubMed ID: 27864703)
1. Longitudinal experience with WHO Grade III (anaplastic) meningiomas at a single institution.
Balasubramanian SK; Sharma M; Silva D; Karivedu V; Schmitt P; Stevens GH; Barnett GH; Prayson RA; Elson P; Suh JH; Murphy ES; Chao ST
J Neurooncol; 2017 Feb; 131(3):555-563. PubMed ID: 27864703
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of radiotherapy and stereotactic radiosurgery as adjuvant or salvage treatment in atypical and anaplastic (WHO grade II and III) meningiomas: a systematic review and meta-analysis.
Gagliardi F; De Domenico P; Snider S; Pompeo E; Roncelli F; Barzaghi LR; Acerno S; Mortini P
Neurosurg Rev; 2023 Mar; 46(1):71. PubMed ID: 36928326
[TBL] [Abstract][Full Text] [Related]
3. Long-term experience with World Health Organization grade III (malignant) meningiomas at a single institution.
Rosenberg LA; Prayson RA; Lee J; Reddy C; Chao ST; Barnett GH; Vogelbaum MA; Suh JH
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):427-32. PubMed ID: 19427553
[TBL] [Abstract][Full Text] [Related]
4. World Health Organization Grade III (Nonanaplastic) Meningioma: Experience in a Series of 23 Cases.
Zhang GJ; Zhang GB; Zhang YS; Li H; Li CB; Zhang LW; Li D; Wu Z; Zhang JT
World Neurosurg; 2018 Apr; 112():e754-e762. PubMed ID: 29382616
[TBL] [Abstract][Full Text] [Related]
5. A retrospective analysis of survival and prognostic factors after stereotactic radiosurgery for aggressive meningiomas.
Ferraro DJ; Funk RK; Blackett JW; Ju MR; DeWees TA; Chicoine MR; Dowling JL; Rich KM; Drzymala RE; Zoberi I; Simpson JR; Jaboin JJ
Radiat Oncol; 2014 Jan; 9():38. PubMed ID: 24467972
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the results of recurrent intracranial meningiomas treated with re-radiosurgery.
Kim M; Lee DH; Kim Rn HJ; Cho YH; Kim JH; Kwon DH
Clin Neurol Neurosurg; 2017 Feb; 153():93-101. PubMed ID: 28081463
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic radiosurgery of World Health Organization grade II and III intracranial meningiomas: treatment results on the basis of a 22-year experience.
Pollock BE; Stafford SL; Link MJ; Garces YI; Foote RL
Cancer; 2012 Feb; 118(4):1048-54. PubMed ID: 21773968
[TBL] [Abstract][Full Text] [Related]
8. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
[TBL] [Abstract][Full Text] [Related]
9. World Health Organization Grade II Meningiomas: The Role of Adjuvant/Salvage Gamma Knife Surgery After Initial Surgery and Prognostic Factor Assessment.
Liu X; Shan B; Wang M; Xu J
World Neurosurg; 2018 Jan; 109():e352-e362. PubMed ID: 28987849
[TBL] [Abstract][Full Text] [Related]
10. Long-term Outcomes After Gamma Knife Radiosurgery for Meningiomas.
Kondziolka D; Patel AD; Kano H; Flickinger JC; Lunsford LD
Am J Clin Oncol; 2016 Oct; 39(5):453-7. PubMed ID: 24755664
[TBL] [Abstract][Full Text] [Related]
11. Treatment of WHO Grade 2 Meningiomas With Stereotactic Radiosurgery: Identification of an Optimal Group for SRS Using RPA.
Kowalchuk RO; Shepard MJ; Sheehan K; Sheehan D; Faramand A; Niranjan A; Kano H; Gurewitz J; Bernstein K; Liscak R; Guseynova K; Grills IS; Parzen JS; Cifarelli CP; Rehman AA; Atik A; Bakhsheshian J; Zada G; Chang E; Giannotta S; Speckter H; Wu HM; Kondziolka D; Mathieu D; Lee CC; Warnick RE; Lunsford LD; Trifiletti DM; Sheehan JP
Int J Radiat Oncol Biol Phys; 2021 Jul; 110(3):804-814. PubMed ID: 33548341
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcome after radiotherapy in patients with atypical and malignant meningiomas--clinical results in 85 patients treated in a single institution leading to optimized guidelines for early radiation therapy.
Adeberg S; Hartmann C; Welzel T; Rieken S; Habermehl D; von Deimling A; Debus J; Combs SE
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):859-64. PubMed ID: 22137023
[TBL] [Abstract][Full Text] [Related]
13. High-precision radiotherapy for meningiomas : Long-term results and patient-reported outcome (PRO).
Kessel KA; Fischer H; Oechnser M; Zimmer C; Meyer B; Combs SE
Strahlenther Onkol; 2017 Nov; 193(11):921-930. PubMed ID: 28620750
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of estrogen receptor in WHO Grade III meningioma: a long-term follow-up study from a single institution.
Hua L; Zhu H; Li J; Tang H; Kuang D; Wang Y; Tang F; Chen X; Zhou L; Xie Q; Gong Y
J Neurosurg; 2018 Jun; 128(6):1698-1706. PubMed ID: 28820306
[TBL] [Abstract][Full Text] [Related]
15. Role of gamma knife surgery for intracranial atypical (WHO grade II) meningiomas.
Hanakita S; Koga T; Igaki H; Murakami N; Oya S; Shin M; Saito N
J Neurosurg; 2013 Dec; 119(6):1410-4. PubMed ID: 24074490
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic radiation treatment for recurrent nonbenign meningiomas.
Mattozo CA; De Salles AA; Klement IA; Gorgulho A; McArthur D; Ford JM; Agazaryan N; Kelly DF; Selch MT
J Neurosurg; 2007 May; 106(5):846-54. PubMed ID: 17542529
[TBL] [Abstract][Full Text] [Related]
17. Revisiting Adjuvant Radiotherapy After Gross Total Resection of World Health Organization Grade II Meningioma.
Graffeo CS; Leeper HE; Perry A; Uhm JH; Lachance DJ; Brown PD; Ma DJ; Van Gompel JJ; Giannini C; Johnson DR; Raghunathan A
World Neurosurg; 2017 Jul; 103():655-663. PubMed ID: 28450233
[TBL] [Abstract][Full Text] [Related]
18. Survival and failure patterns in atypical and anaplastic meningiomas: A single-center experience of surgery and postoperative radiotherapy.
Kumar N; Kumar R; Khosla D; Salunke PS; Gupta SK; Radotra BD
J Cancer Res Ther; 2015; 11(4):735-9. PubMed ID: 26881510
[TBL] [Abstract][Full Text] [Related]
19. An evidence-based treatment algorithm for the management of WHO Grade II and III meningiomas.
Sun SQ; Hawasli AH; Huang J; Chicoine MR; Kim AH
Neurosurg Focus; 2015 Mar; 38(3):E3. PubMed ID: 25727225
[TBL] [Abstract][Full Text] [Related]
20. The role of radiotherapy in the management of high-grade meningiomas.
Hwang KL; Hwang WL; Bussière MR; Shih HA
Chin Clin Oncol; 2017 Jul; 6(Suppl 1):S5. PubMed ID: 28758409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]